EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 1-Nov-2025 12:11 ET (1-Nov-2025 16:11 GMT/UTC)

29-Oct-2025

Artificial intelligence takes the lead in revolutionizing cancer research explored at NFCR’s 2025 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.

National Foundation for Cancer Research
Meeting Announcement

The National Foundation for Cancer Research (NFCR) hosted its 2025 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on October 24 at the National Press Club, in Washington, D.C., gathering many of the most forward-thinking minds in oncology, cancer research, technology, patient care, and biomedical innovation.

This year’s summit centered on a defining theme: how artificial intelligence (AI) is reshaping the entire ecosystem of cancer research and patient care, from laboratory discovery to bedside decision-making.

28-Oct-2025

Allison Institute’s third annual scientific symposium highlighted by panel discussion with five Nobel laureates

University of Texas M. D. Anderson Cancer Center
Meeting Announcement

Sessions focused on the latest advances in cancer vaccines, immunotherapy and immunology research

Symposium featured a panel discussion with five Nobel laureates, moderated by TIME Senior Health Correspondent Alice Park

28-Oct-2025

Research spotlight: Implantable “CANDI” wafer shows promise for preventing glioblastoma recurrence

Mass General Brigham
Peer-Reviewed Publication

Yannik Kaiser, MD-candidate, and Ralph Weissleder, MD, PhD, of the Center for Systems Biology at Massachusetts General Hospital and Harvard Medical School are the lead and corresponding authors of a paper published in Nature Biomedical Engineering, “Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence.”

Journal: Nature Biomedical Engineering
Funder: National Institute of Health Sciences, Swiss Institute for Experimental Cancer Research, German Academic Exchange Service

28-Oct-2025

Johns Hopkins-led study finds drugs approved for treating pain also reduce bone cancer growth

Johns Hopkins Medicine
Peer-Reviewed Publication

A multicenter research team led by Johns Hopkins Medicine reports that two analgesic drugs, bupivacaine and rimegepant, not only relieve tumor-associated pain in laboratory mice, but also slow the unchecked growth of osteosarcomas.

Journal: Proceedings of the National Academy of Sciences
Funder: National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (NIH), National Institute of Neurological Disorder and Stroke at NIH, National Institute of Dental and Craniofacial Research at NIH, National Institutes of Health, Department of Defense

28-Oct-2025

Targeted radiation during surgery reduces pancreatic cancer recurrence

Johns Hopkins Medicine
Peer-Reviewed Publication

Using targeted radiation during surgery — referred to as intraoperative radiation — to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the recurrence rate around the pancreas to 5%. This is believed to be the lowest ever reported for this population of patients, according to a preliminary study by the team from the Johns Hopkins Kimmel Cancer Center.

Journal: International Journal of Radiation Oncology*Biology*Physics

28-Oct-2025

MD Anderson’s top nurses receive The Brown Foundation Award for Excellence in Oncology Nursing

University of Texas M. D. Anderson Cancer Center
Grant and Award Announcement

The University of Texas MD Anderson Cancer Center yesterday honored Kimberly Vanderhorst, MSN, RN, CAPA, and Terri Lynn Dunn, DNP, APRN, WHNP-BC, CPHQ, with the 2025 Brown Foundation Award for Excellence in Oncology Nursing. As the institution’s highest nursing honor, this award celebrates outstanding achievements in oncology nursing, including exceptional patient care and a commitment to excellence in clinical practice.

28-Oct-2025

Leading the way in targeted cancer treatment

University of Missouri-Columbia
Peer-Reviewed Publication

In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the solution may lie in tiny bubble-shaped packages that cells use to talk to each other.

Journal: Molecular Therapy Oncology

28-Oct-2025

Dicer: Life's ancient repair tool

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

CSHL Professor & HHMI Investigator Rob Martienssen has found that both the Dicer protein and RNase H enzyme are needed to fully resolve conflicts between DNA transcription and replication. The discovery could have significant implications for how we think about cancer and the origins of life.

Journal: Molecular Cell
Funder: NIH/National Institutes of Health, Howard Hughes Medical Institute, Institut Curie, Centre National de la Recherche Scientifique, Agence Nationale de la Recherche, Ligue Contre le Cancer

28-Oct-2025

UT Health San Antonio recognized among nation’s top 100 oncology programs

The University of Texas at San Antonio Health Science Center
Business Announcement

UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review.

28-Oct-2025

AI tool identifies women at high risk of interval breast cancer

Radiological Society of North America
Peer-Reviewed Publication

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancers, breast cancer that is diagnosed between regular screening mammograms.

Journal: Radiology